In addition, immunotherapeutic drugs combined with other classical drugs have also shown good efficacy in a variety of tumors, such as ICIs combined with angiogenesis inhibitors for liver cancer or combined with BRAF inhibitors for advanced melanoma with BRAF V600 mutation14,15. Here, BRAF is linked to melanoma.